Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Downgrades Vyant Bio to Neutral

HC Wainwright & Co. Downgrades Vyant Bio to Neutral

HC Wainwright & Co. analyst Edward White downgrades Vyant Bio (NASDAQ:VYNT) from Buy to Neutral.

byBenzinga Newsdesk

February 3, 2023

1 minute read

HC Wainwright & Co. analyst Edward White downgrades Vyant Bio (NASDAQ:VYNT) from Buy to Neutral.

News
Rumors

‘Netflix Will Be Next On Microsoft’s Shopping List’ – Reuters News

By Benzinga Newsdesk

December 20, 1:27 PM

https://www.reuters.com/breakingviews/netflix-will-be-next-microsofts-shopping-list-2022-12-20/#:~:text=NEW%20YORK%2C%20Dec%2020%20(Reuters,to%20the%20list%20in%202023. Satya Nadella keeps thinking bigger.

MSFT

Analyst Ratings

11 Analysts Have This to Say About Cheesecake Factory

By Benzinga Insights

May 11, 10:01 AM

Over the past 3 months, 11 analysts have published their opinion on Cheesecake Factory (NASDAQ:CAKE) stock. These analysts…

CAKE

Biomea Fusion Highlights Initial Data From The First Two Type 1 Diabetes Patients Dosed With BMF-219

By Benzinga Newsdesk

April 1, 9:04 AM

BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes The first two type 1 diabetes patients enrolled in COVALENT-112 both

BMEA